FLII
Basic information
Region (hg38): 17:18244815-18258738
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, dilated, 2J | AR | Cardiovascular | Individuals can manifest with severe and early-onset cardiomyopathy, and awareness can allow early diagnosis and management | Cardiovascular | 32870709; 37561591 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FLII gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 23 | ||||
missense | 72 | 80 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | 4 | |||
non coding | 3 | |||||
Total | 0 | 1 | 73 | 26 | 8 |
Variants in FLII
This is a list of pathogenic ClinVar variants found in the FLII region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-18245155-A-G | not specified | Likely benign (Mar 28, 2022) | ||
17-18245162-G-A | Likely benign (Aug 15, 2018) | |||
17-18245176-A-G | High myopia | Uncertain significance (Dec 17, 2018) | ||
17-18245230-G-A | Primary dilated cardiomyopathy • Cardiomyopathy, dilated, 2j | Likely pathogenic (May 06, 2021) | ||
17-18245235-C-T | not specified | Likely benign (Jun 18, 2024) | ||
17-18245236-G-A | not specified | Uncertain significance (Dec 12, 2022) | ||
17-18245406-A-G | not specified | Uncertain significance (Sep 04, 2024) | ||
17-18245570-T-A | Benign (Dec 31, 2019) | |||
17-18245587-C-T | not specified | Uncertain significance (Nov 11, 2024) | ||
17-18245648-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
17-18245651-G-A | Likely benign (Feb 01, 2023) | |||
17-18245745-G-A | Cardiomyopathy, dilated, 2j | Pathogenic (Nov 28, 2023) | ||
17-18245770-C-G | not specified | Uncertain significance (Sep 27, 2024) | ||
17-18245779-G-A | Benign (Dec 31, 2019) | |||
17-18245782-A-G | Likely benign (Jul 01, 2024) | |||
17-18245799-C-A | Uncertain significance (Dec 01, 2023) | |||
17-18245821-G-T | not specified | Uncertain significance (Sep 27, 2024) | ||
17-18245838-C-T | not specified | Uncertain significance (May 26, 2023) | ||
17-18245994-G-A | not specified | Likely benign (Jul 01, 2024) | ||
17-18246011-G-A | not specified | Uncertain significance (Dec 12, 2023) | ||
17-18246051-C-G | not specified | Uncertain significance (Oct 21, 2021) | ||
17-18246182-C-G | not specified | Uncertain significance (May 30, 2023) | ||
17-18246193-A-C | not specified | Uncertain significance (Mar 29, 2022) | ||
17-18246335-C-T | not specified | Uncertain significance (Dec 21, 2023) | ||
17-18246336-G-A | not specified | Uncertain significance (Sep 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FLII | protein_coding | protein_coding | ENST00000327031 | 30 | 14081 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.53e-12 | 1.00 | 125633 | 0 | 115 | 125748 | 0.000457 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.507 | 753 | 793 | 0.949 | 0.0000527 | 8321 |
Missense in Polyphen | 242 | 280.75 | 0.86199 | 2922 | ||
Synonymous | -1.97 | 379 | 333 | 1.14 | 0.0000224 | 2439 |
Loss of Function | 4.23 | 31 | 68.9 | 0.450 | 0.00000352 | 757 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000679 | 0.000679 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000925 | 0.0000924 |
European (Non-Finnish) | 0.000331 | 0.000325 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00167 | 0.00167 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role as coactivator in transcriptional activation by hormone-activated nuclear receptors (NR) and acts in cooperation with NCOA2 and CARM1. Involved in estrogen hormone signaling. Involved in early embryonic development (By similarity). May play a role in regulation of cytoskeletal rearrangements involved in cytokinesis and cell migration, by inhibiting Rac1-dependent paxillin phosphorylation. {ECO:0000250, ECO:0000269|PubMed:14966289}.;
Recessive Scores
- pRec
- 0.234
Intolerance Scores
- loftool
- 0.779
- rvis_EVS
- -2.94
- rvis_percentile_EVS
- 0.55
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.618
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.787
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Flii
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- flii
- Affected structure
- fast muscle cell
- Phenotype tag
- abnormal
- Phenotype quality
- disorganized
Gene ontology
- Biological process
- multicellular organism development;actin cytoskeleton organization;actin filament severing
- Cellular component
- nucleoplasm;microtubule organizing center;cytosol;brush border;focal adhesion
- Molecular function
- actin binding;protein binding;actin filament binding